Home | Infections | Hepatitis

Hepatitis

Hepatitis C clinic's expertise, dedication aids patients

by Joe Evans, Nebraska Medicine - Mark Mailliard, M.D., chief of the division of gastroenterology and hepatology at UNMC. ...

Hepatitis C prevention and control efforts should focus on incarcerated individuals, according to new study

By Corinne Ton That - More than one in nine people with hepatitis C in Canada spend time in a correctional facility ...

Hepatitis C screening of prison inmates would benefit wider community and be cost-effective

The benefits of screening prison inmates for infection with the hepatitis C virus (HCV) and treating those who test positive for the infection would extend far beyond the prison population, according to projections made by investigators from Massachusetts General Hospital (MGH),the University of Pittsburgh Graduate School of Public Health, Georgia Institute of Technology and Emory University. ... Full story

Enhanced treatment for hepatitis C could cut prevalence by 80%

By Ziba Kashef - Novel antiviral therapies for hepatitis C could reduce the prevalence of the blood-borne infection by more than 80%, according to an analysis by Yale researchers. The finding raises the possibility of greatly reducing, and even eliminating, hepatitis C in the United States if enhanced screening and treatment efforts target high-risk populations. ... Full story

Cell research shows pathway for suppressing hepatitis B virus

(Okayama ) Research led by Okayama University Graduate School of Medicine identifies the signalling pathway for hepatitis B virus recognition and suppression, suggesting a possible anti-viral strategy for the disease. ... Full story

Trinity Scientists Homing in on New Hepatitis C Vaccine

Trinity researchers have just commenced a major new study to evaluate a new vaccine for the prevention of Hepatitis C infection in HIV patients, who are at increased risk of contracting the common infection. ... Full story

Expensive Drugs That Cure Hepatitis C Are Worth The Cost, Even At Early Stages Of Liver Fibrosis

By Laura Kurtzman - It is worthwhile to give patients expensive new drugs that can cure their hepatitis C much earlier than some insurers are now willing to pay for them, according to a UC San Francisco study that models the effects of treating the disease early versus late in its development. ... Full story

Antiviral Therapy Shows Hope for Advanced Kidney Disease Patients with Hepatitis C Virus Infection

A University of Miami Miller School of Medicine researcher has played a principal role in an international phase III study, known as the C-SURFER trial, of the effect of direct-acting antiviral therapy for hepatitis C virus (HCV) infection in patients with chronic kidney disease stage 4 or 5. The therapy has shown positive results — a first for patients with advanced kidney disease. ... Full story

Nearly Half of Hepatitis C Patients on Medicaid Denied Coverage for Life-Saving Drugs, Penn Researchers Report

First Data to Report on Denial and Delay Rates for Hepatitis C Antiviral Agents ... Full story

Study: Three-drug combos eliminate hepatitis C virus genotype 1b infection in three weeks

By Quinn Eastman - A pilot study has found that a combination of drugs used to treat the hepatitis C virus could substantially reduce the time of treatment to as little as three weeks for some patients. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 103 | displaying: 1 - 10